Department of Anaesthesia and Intensive Care, Government Medical College and Hospital Chandigarh, Chandigarh, India.
Pain Pract. 2012 Jul;12(6):485-96. doi: 10.1111/j.1533-2500.2011.00513.x. Epub 2011 Oct 19.
Pain relief after laparoscopic cholecystectomy (LC) is an issue of great practical importance. Pain after LC has several origins: incisional, local visceral, peritoneal, and referred. Several modalities have been employed for achieving effective and safe analgesia: nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors, gabapentinoids, local anesthetics, and transversus abdominis plane (TAP) block. They have their advantages and disadvantages, and multimodal approaches are often followed because of the multiple sources of pain. Among COX-2 inhibitors, parecoxib and valdecoxib are useful, and fears regarding their cardiovascular adverse effects in noncardiac surgery (such as LC) have not been substantiated when used in short term. Gabapentin is useful but more data are needed regarding pregabalin because of inconsistent results. Local anesthetics (LA) can be particularly useful, both port-site infiltration and intraperitoneal instillation in the intra-operative period. Factors enhancing the effectiveness of these agents include early instillation before creating the pneumoperitoneum, larger volume of medium used for instillation, and favorable pharmacological characteristics of the agent. Combination of LA with either NSAID/COX-2 inhibitors or fibrin sealant appears to be effective, although more research is required for determining the exact combinations and efficacy using direct comparisons with single-modality interventions. Finally, newer procedures such as TAP block appear promising if replicated.
腹腔镜胆囊切除术 (LC) 后的止痛是一个非常重要的实际问题。LC 后的疼痛有几个来源:切口、局部内脏、腹膜和牵涉痛。已经采用了多种方法来实现有效和安全的镇痛:非甾体抗炎药 (NSAIDs) 和环氧化酶-2 (COX-2) 抑制剂、加巴喷丁类药物、局部麻醉剂和腹横肌平面 (TAP) 阻滞。它们各有优缺点,由于疼痛的多个来源,通常采用多模式方法。在 COX-2 抑制剂中,帕瑞昔布和伐地昔布很有用,并且在短期使用时,关于它们在非心脏手术(如 LC)中对心血管不良影响的担忧并未得到证实。加巴喷丁很有用,但由于结果不一致,需要更多关于普瑞巴林的数据。局部麻醉剂 (LA) 在术中特别有用,包括在切口部位浸润和腹腔内灌注。增强这些药物效果的因素包括在建立气腹前早期灌注、使用更大体积的灌注介质以及药物的有利药理学特性。LA 与 NSAID/COX-2 抑制剂或纤维蛋白密封剂联合使用似乎有效,尽管需要更多的研究来确定使用与单一模式干预的直接比较的确切组合和疗效。最后,如果复制,TAP 阻滞等新程序似乎很有前途。